Kunming Guiyan Pharmaceutical Co., Ltd. (KGP), founded in June 2004, is a company focusing on manufacturing and developing Pt-drugs. The company has 25 staff members, of whom 3 being senior engineers and 7 being engineers; in terms of academic degrees, there is 1 Ph D and 3 master bearers. The company has a total working area of 2100m2, including the normal manufacturing zone, the clean zone, product quality control center, new drug research and development labs and recycling workshop of precious metals. Equipped with manufacturing equipments and testing instruments, the company boasts 9 authorized patents covering techniques such as product preparing methods, pharmaceutical formulation, precious metals recycling and production process monitoring. In August, 2009, KGP passed the National New High-tech enterprise authentication, and the main products: Cisplatin, Carboplatin, Oxaliplatin passed the Chinese national GMP authentication and got CEP certificates. The company produces Nedaplatin, Satraplatin, Picoplatin, the critical intermediate of Pt-drugs, and has relevant preparation techniques and of antitumor Pt-drugs reference standard recorded in the pharmacopeia. The company is also exploring techniques to develop new Pt-drugs and organic antitumor drugs.